MedTrace Logo

Influence of Lens Design on Particulate Exchange in the Post-lens Tear Film

NCT03782571 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2020-05-12

Study results available
· View outcomes & findings →

Summary

This is a 5-visit, controlled, bilateral, randomized, subject-masked, crossover (4 treatments x 4 period), non-dispensing study. Subjects will attend all study visits in their spectacle correction having not worn contact lenses on the day of the visit.

Conditions

  • Visual Acuity

Interventions

DEVICE

etafilcon a Test 1

1-DAY ACUVUE® MOIST

DEVICE

etafilcon A Test 2

1-DAY ACUVUE® MOIST for ASTIGMATISM

DEVICE

etafilcon A Test 3

1-DAY ACUVUE® MOIST MULTIFOCAL

OTHER

Control

Bare Eye

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-16
Primary Completion
2019-03-25
Completion
2019-03-25
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03782571 on ClinicalTrials.gov